Temozolomide+Irinotecan+Vincristine

DRUG2 trials

Sponsors

Sun Yat-sen University, Yizhuo Zhang

Conditions

Rhabdomyosarcoma, ChildSoft Tissue Sarcoma

Phase 2

Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study

RecruitingNCT05457829

Sun Yat-sen UniversityRhabdomyosarcoma, Child

Start: 2023-12-30End: 2026-07-31Target: 88Updated: 2026-05-18

Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.

RecruitingNCT06514313

Yizhuo ZhangSoft Tissue Sarcoma

Start: 2024-07-03End: 2026-12-01Target: 110Updated: 2024-07-23